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need to perceive and efficiently
respond to their microenvironment.
Signals can propagate in many ways,
including changes in pH, diffusion,
chemical reactions, or physical bind-
ing; they can also take place through
second messengers (1). Signals are
received via allosteric events that
perturb the molecular conformation
of a target macromolecule. Second
messenger binding initiates intracel-
lular signal transduction cascades that
trigger physiological changes; these
often couple to kinase cascades that
amplify the breadth of the first extra-
cellular signal. Cyclic AMP (2,3) and
Ca2þ (4) are among the commonly
used second messengers in eukaryotic
signaling systems. Cyclic AMP
(cAMP) is synthesized by adenylyl
cyclase after stimulation by a hor-
mone-activated G protein-coupled
receptor. While cellular responses are
largely the outcome of long range
allosteric propagation, insight into
signaling at the conformational level
must be obtained by probing allosteric
effects on a single-molecule level (5).
Time-dependent signaling bursts
must both initiate and terminate, but
most of the detailed studies focus onhttp://dx.doi.org/10.1016/j.bpj.2015.07.007
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the Biophysical Journal, Krishnamur-
thy et al. (6) provide a unique, in-depth
view of the termination step for cAMP
signaling by the cytosolic cAMP
receptor, protein kinase A (PKA) regu-
latory subunit, carried out by phospho-
diesterase (PDE). PKA regulatory
subunit and PDE from Dictyostelium
discoideum (RD and RegA, respec-
tively) were used as a model system.
On its own, cAMP-dependent protein
kinase A (PKA) exists as an inactive
complex of the regulatory and catalytic
subunits. Signaling initiates upon bind-
ing of cAMP to the regulatory subunit
(RD), which elicits conformational
changes that result in the release of
the active catalytic subunit. Signaling
terminates through the action of cAMP
PDE, which forms direct interactions
with the cyclic nucleotide binding
(CNB) domain of PKA regulatory sub-
unit and hydrolyzes cAMP to 50AMP.
Importantly, the high local concen-
trations of cAMP in the cell preclude
reassociation of the catalytic and regu-
latory domains of PKA. Consequently,
signal termination occurs only when
the cAMP population is drained by
phosphodiesterase hydrolysis.
Earlier (3), the authors proposed a
mechanism for termination of signal-
ing through the activity of a PDE
bound near the second cAMP binding
site on RD (CNB:B), whereby substrate
channeling between cAMP sites in RD
delivers cAMP to the active site of
PDE for hydrolysis. This channeling
proposition aimed to address the puz-
zling question of how cAMP, which
binds with high affinity (nM Kd) at
RD’s CNB:A, can be hydrolyzed at
PDE’s active site. Krishnamurthy
et al. (3) argued that without direct
interactions between RD and PDE,
PDE’s cAMP hydrolysis activity and
thus signal termination would be
limited by the very slow off-rate for
the dissociation of cAMP from RD.
Thus the authors hypothesized that
PDEs bind RD, eliciting a confor-
mational change that promotes cAMP
dissociation from CNB:A. cAMP insolution is then channeled through
CNB:B to the active site of the PDE.
In this issue of the Biophysical
Journal, Krishnamurthy et al. (6) focus
on the significant question of how
RD:PDE complex formation and disso-
ciation take place, illustrating for the
first time, to our knowledge, a mecha-
nism through which cAMP signaling
can be terminated in a timely manner
through allostery. Amide hydrogen/
deuterium exchange mass spectrom-
etry (HDXMS) (7,8) is a powerful
conformational probe tool for mapping
allosteric signaling, identifying flex-
ible and disordered regions. Here
HDXMS is exploited to monitor slow
conformational transitions in RD.
Krishnamurthy et al. (3) show that
at high cAMP concentrations, RD and
PDE form a stable complex, with
PDE interacting at RD’s CNB:B. This
validates the formation of the proposed
stable ternary complex in cAMP signal
termination. The authors propose that
such a complex permits substrate
channeling, in accord with the model
for coordinated cAMP hydrolysis
discussed above. The channel model
is in agreement with all their experi-
mental data and leads the authors to
postulate that signaling will persist
for as long as cAMP channeling per-
sists. Once the cAMP pool is depleted,
signaling will terminate. In the absence
of cAMP, the destabilized complex
will dissociate, and RD will reassociate
with the catalytic subunit of PKA, with
the departing PDE allosterically prim-
ing RD for its autoinhibition role.
According to this scenario, allostery
plays two important roles in the
termination of cAMP signaling. First,
PDE binding allosterically promotes
the release of the tightly bound cAMP
from RD’s CNB:A, kinetically increas-
ing the local concentration of cAMP.
Second, channeling of cAMP via RD’s
CNB:B to PDE’s active site helps
PDE efficiently hydrolyze cAMP. This
implies that the temporally regulated
New & Notable 1081expression level of PDE corresponds to
a precisely regulated termination of
PKA activation through allostery.
This remarkable scenario fits well
the HDXMS data (6). Importantly,
the substrate channeling model of
Krishnamurthy et al. (3,6) implies
that PDE alone cannot efficiently hy-
drolyze cAMP. Measurements of the
catalytic kcat and Km of PDE (9) in
the presence and absence of RD could
verify the critical role of allostery in
cAMP hydrolysis. Kinetic data might
indicate the possibility of an alterna-
tive allosteric activation taking place
through a conformational change in
PDE elicited by RD binding. The data
in Krishnamurthy et al. (6) clearly
illustrate that in the absence of
cAMP, PDE does not bind RD. This
fact tells us that one function of the
allosteric interaction between PDE
and RD binding is to ensure that PDE
(even if it is already expressed in the
cell) is precisely activated only when
the cAMP level is high.
Finally, it is noteworthy that Krish-
namurthy et al. (6) observe that at
short timescales, the conformational
flexibility at CNB:A decreases upon
cAMP binding, whereas at long time-scales, it increases. This suggests
broader ensembles including confor-
mational changes far away, as well as
possible perturbations upon ligand
dissociation. This significant observa-
tion argues that probing binding site
flexibility without accounting for time
regimes may not capture accurately
the conformational attributes upon
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